🇺🇸 conventional treatment for schizophrenia in United States

conventional treatment for schizophrenia (conventional treatment for schizophrenia) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

conventional treatment for schizophrenia in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is conventional treatment for schizophrenia approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for conventional treatment for schizophrenia in United States?

AstraZeneca is the originator. The local marketing authorisation holder may differ — check the official source linked above.